Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Uncategorized

TD Securities Maintains Hold on Domtar, Raises Price Target to $56

TD Securities maintains Domtar (NYSE:UFS) with a Hold and raises the price target from $51 to $56.

byBenzinga Newsdesk

May 12, 2021

1 minute read

TD Securities maintains Domtar (NYSE:UFS) with a Hold and raises the price target from $51 to $56.

FDA
News

Turning Point Therapeutics Reports Was Granted FDA Orphan Drug Designation For TPX-0022 In Gastric Cancer

By Benzinga Newsdesk

Today, 8:02 PM

Turning Point Therapeutics, Inc. (NASDAQ:TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced that TPX-0022, the company’s inhibitor of MET

TPTX

Legal
News

S. Korean Internet Service Provider SK Broadband Sued Netflix to Pay for Costs Related to Increased Network Traffic

By Charles Gross

Today, 8:02 PM

-Reuters https://www.reuters.com/business/media-telecom/skorea-broadband-firm-sues-netflix-after-traffic-surge-squid-game-2021-10-01/

NFLX

Analysts Bump Up UPS Price Target Post Q4 Results

By Akanksha Bakshi

Today, 8:02 PM

Analysts updated the price target fo

UPS

B of A Securities Downgrades IPG Photonics to Underperform, Lowers Price Target to $173

By Benzinga Newsdesk

Today, 8:02 PM

B of A Securities analyst Michael Feniger downgrades IPG Photonics (NASDAQ:IPGP) from Neutral to Underperform and lowers the price target from $178 to $173.

IPGP

TD Securities Maintains Hold on Domtar, Raises Price Target to $56

Related Posts

Turning Point Therapeutics Reports Was Granted FDA Orphan Drug Designation For TPX-0022 In Gastric Cancer

S. Korean Internet Service Provider SK Broadband Sued Netflix to Pay for Costs Related to Increased Network Traffic

Analysts Bump Up UPS Price Target Post Q4 Results

B of A Securities Downgrades IPG Photonics to Underperform, Lowers Price Target to $173